Presentation on theme: "Antipsychotics & beyond: what you need to know"— Presentation transcript:
1 Antipsychotics & beyond: what you need to know Originally Presented February 26, 2013Updated June 19, 2013
2 Antipsychotic Drugs and the Regulatory System Ellen J. Mullins RN Research and Development Director, The Compliance Store
3 Survey and Certification Letters S&C Letter VideosS&C Letter ClarificationsManual InstructionAdvanced CopyEffective Date
4 No Regulation Changes Interpretive Guidance Guidance to Surveyors Interpretation
5 Dementia Care Principles Person Centered CareQuality and Quantity of StaffEvaluation of New and Worsening SymptomsIndividualized Approaches to CareCritical Thinking re: Antipsychotic Drug UseInterviews with PrescribersEngagement of Resident and Family in Decision Making
6 Surveyor Focus “Process of Care” Interviews Observations Record Reviews
8 Be Prepared!List of residents with dementia and orders for antipsychotic medications past 30 daysArticulate how individualized care is provided to residents with dementiaPolicy for use of antipsychotic medications in residents with dementia
9 F-309 – Quality of CareAddresses care areas not specifically covered by other F-tags in this regulatory groupingNo investigative protocolChecklist: “Review of Care and Services for a Resident with Dementia”
10 F-329 – Unnecessary DrugsFour new medications added to the list of antipsychotic medications:SaphrisFanaptLatudaInvega
11 Antipsychotic Medication Indications for Use:SchizophreniaSchizo-affective disorderSchizophreniform disorderDelusional disorderMood disordersPsychosis in the absence of dementiaMental Illnesses with psychotic symptomsTourette’s disorderHuntington diseaseHiccupsNausea and vomiting
12 BPSD Behavioral or Psychological Symptoms of Dementia “Antipsychotic medications may be considered for elderly residents with dementia but only after medical, physical, functional, psychological, emotional psychiatric, social and environmental causes have been identified and addressed. Antipsychotic medications must be prescribed at the lowest possible dose for the shortest period of time and are subject to gradual dose reduction and re-review.”
13 Inadequate Indications WanderingPoor self-careRestlessnessImpaired memoryMild anxietyInsomniaInattention/indifference to surroundingsSadness or crying unrelated to depression or psychiatric disordersFidgetingNervousnessUncooperativenessCriteria for Antipsychotic Drug Use:Behavior is a danger to resident or others ANDSymptoms are due to mania or psychosis ORInterventions attempted and included in the care plan(except in an emergency)
14 Emergency Use of Antipsychotic Medications Criteria in the prior slide must be met IN ADDITION TO ALL OF THE FOLLOWING…Acute treatment period is 7 days or lessClinician evaluation and documentation within 7 daysUnderlying causesContributing factorsVerification of the need to continue the antipsychotic medicationPersistent behaviorsNonpharmacological interventionsAttempted – unless contraindicatedDocumented
15 Enduring Conditions Clearly identify and document the target behavior Monitoring must include:Assuring the cause is not a medical condition or medicationEnvironmental stressorsPsychological stressorsPersistence that negatively affects quality of life
16 New Admissions Attempt to identify an indication for use PASRR Physician’s ordersWithin 2 weeks, re-evaluate the use of the medication to consider reduction or discontinuation
17 “The facility MUST act upon this!” Adverse Consequences“The facility MUST act upon this!”The facility AND prescriber MUST document the rationale for the decision and the inclusion of the resident or family in the decision.
18 Documentation Diagnosis Expected outcome Monitoring of resident responseRisk / benefitAdverse consequencesRe-evaluation of behavioral symptomsContinued effectivenessPotential reduction
19 Prioritize Dose Reduction Efforts Avoid initiating antipsychotic drugs for residents not currently taking themRe-evaluate residents recently prescribed antipsychotic drugs for the first timeCarefully assess all residents admitted with antipsychotic drugs for reason/benefit/side effects and reduction/eliminationResidents with long term antipsychotic use should be carefully evaluated for dose reduction or elimination of antipsychotic drug use
20 F-329 – Antipsychotic Drugs Based on a comprehensive assessment of a resident, the facility must ensure that –Residents who have not used antipsychotic drugs are not given these drugs unless antipsychotic drug therapy is necessary to treat a specific condition as diagnosed and documented in the clinical record;Residents who use antipsychotic drugs receive gradual dose reductions, and behavioral interventions, unless clinically contraindicated, in an effort to discontinue these drugs.
21 How Do We Reduce Our Reliance on Antipsychotics? Cheryl Swann RN-BC, BSN, WCC, LNHA Vice President of Content, Relias Learning
22 Getting Started on Reducing Antipsychotics Form a committee – an interdisciplinary team (IDT) to:Review residents’ diagnoses and medicationsDementia diagnosis priorityReason for medicationLast dose reductionReview behavior tracking log
23 Trends the IDT Will Find A large number of behaviors in residents with dementia occur during personal careBathingDressingIs this behavior inappropriate?
24 A Look at the Behavior Tracking Log Analyze the behavior tracking logs to determine if there is a particular trigger for the resident’s behaviorsShiftStaffing
25 Meaning Behind the Behavior All behavior has meaningShift from “How do I stop behaviors?” to “What are these behaviors trying to tell me?”Rule out medical causesPain, constipation, infection, deliriumLook at current medicationsTalk to the familyKnow the resident
26 Behavioral Triggers Three types of triggers: InternalEnvironmentalCaregiverMust evaluate behavioral triggers to determine the most appropriate behavioral intervention
27 Behavioral Interventions Internal triggersEliminate physical factors, such as pain, hunger, or elimination needsProvide stimulating, interactive exercise or activitiesProvide one-to-one careRedirection
29 Behavioral Interventions Caregiver triggersConsistent assignmentsDoes the staff working with the resident know them?What is in the care plan?What do they like/dislike?How do they typically communicate needs/react in certain situations?How is information communicated?Allow to make simple decisions and choices
30 Behavioral Interventions Understand or explain the rationale for interventions/approachesMonitor the effectiveness of those interventions/approachesProvide ongoing assessment as to whether they are improving or stabilizing the resident’s status or causing adverse consequences
31 Documentation and Proof New Survey ProcessCompliance with care planStaff knowledgeable of behaviorsWhat did you do to try and figure out the cause of the behavior?What was the resident communicating with his/her behavior?What was the reason for the resident acting out?What interventions did you try to reduce the behavior?
32 Care Process for a Resident with Dementia Recognition and assessmentCause identification and diagnosisDevelopment of care planIndividualized approaches and treatmentMonitoring, follow-up and oversightQuality assessment and assurance (QAA)
33 Recognition and Assessment Past life experiencesCognitive statusPresence of pain, medical conditions, medicationsPreferences for daily routines, food, music, exerciseHow do they communicate physical needs?Description of behaviors (specific)
34 Cause Identification and Diagnosis Meaning behind behaviorMedical/psychiatric conditionsMedicationsLook at root causeBoredomChanges in routineUnmet needsEnvironmental
35 Develop Care Plan Well-defined problem-statement/outline goals of care Identify staff responsibilities to implement approachesGoals to monitor the effectivenessCollaboration with resident and family
36 Monitoring and Follow Up Staff monitors and documents the effectiveness of interventions to target behaviorsInterventions changed as neededCollaborate with physician regarding medications
37 Quality Assessment and Assurance Resident care policies reflect the facility’s approach to care of residents with dementiaHow the facility ensures that appropriate interventions are usedSufficient staffingData to monitor pharmacological and non-pharmacological interventionsFacility’s response to concerns identified during pharmacy review
38 Quality Assessment and Assurance Staff trainingUnderstanding the Meaning Behind Behaviors – Actions and ReactionsPsychotropic Medications – Antipsychotics and Beyond
39 Measurement of Psychoactive Medications and Continuous Quality Improvement Theresa Schmidt MA, RAC-CT Manager of Education, eHealth Data Solutions
40 GoalsUnderstand how CMS measures antipsychotic medications in CASPER and Nursing Home CompareIdentify which residents trigger these measures and whyCompare your performance to benchmarksAssess effectiveness of interventions and progress over time through trend and SPC chartsEllen and Cheryl have highlighted the importance of ensuring that antipsychotic medications are used only used when appropriate and given you some suggestions for how to accomplish this in your facility. Now we turn our attention to the way in which you will be measured by CMS, Surveyors, and the general public.To succeed in any endeavor, you have to know the rules. In this portion of the program, we will learn how the measures of antipsychotic medications are calculated, how to identify why individual residents are triggering, how to compare your own performance to benchmarks, and finally how to assess the effectiveness of your interventions and your progress over time.
41 Antipsychotic Quality Measures Short-Stay MeasureLong-Stay MeasurePercent Short-Stay Residents Who Newly Received Antipsychotic N0410A=[1,2,3,4,5,6,7]Target MDS must be different from initial MDSExclusions:Antipsychotic use on initial MDSSchizophrenia, Tourette’s, Huntington’sPercent Long-Stay Residents Who Received Antipsychotic N0410A=[1,2,3,4,5,6,7]Exclusions:Schizophrenia, Tourette’s, Tourette’s on prior assessment, Huntington’sThere are 2 Antipsychotic Quality Measures that appear on Nursing Home Compare, and in the CASPER reporting system, a h Short Stay and Long Stay measures. Both of these measures come from MDS Field N0410A.Percent Short-Stay Residents Who Newly Received Antipsychotic selects residents who have been in the facility for fewer than 101 days who have had at least two assessments.Residents will trigger this measure when they received an antipsychotic medication any number of days in the lookback period and were NOT coded as receiving antipsychotics on the initial MDS assessment.They will be excluded if they are coded for Schizophrenia, Tourette’s, or Huntington’s.The long stay measure uses the same field from the MDS, but does not exclude residents who received antipsychotics on the initial MDS. This is because long stay residents have been in the facility for more than 101 days, so staff has had the opportunity to consider dose reduction and other interventions.The measure will not trigger for residents with Schizophrenia, Tourette’s, Tourette’s on prior assessment, or Huntington’s.The full calculation of each of these measures appears in the supplementary materials of this power point.
42 Long-Stay vs. Short-Stay Select all residents whose latest episode either ends during the target period or is ongoing at the end of the target periodThis latest episode is selected for QM calculationFor each episode that is selected, compute the cumulative days in the facility (CDIF)If the CDIF is less than or equal to 100 days, the resident is included in the short-stay sampleIf the CDIF is greater than or equal to 101 days, the resident is included in the long-stay sample
43 Nursing Home Compare Measures Available to the public at homecompareLong-stay and short-stay antipsychotic medication measures were added in summer, 2012Key measure of Psychoactive medications are found on the Nursing Home Compare Quality Measures Reports.Medicare.gov’s Nursing Home Compare website provides publicly available information to allow consumers to compare Medicare or Medicaid certified Nursing Homes. This info includes Five-star quality ratings, health inspection results, nursing home staffing information, quality measures, along with penalties and enforcement actions against nursing homes.In the summer of 2012, Nursing Home Compare added both long stay and short stay antipsychotic quality measures. These measures have now been added to CASPER and replaced the prior Psychoactive Medication surveyor measure.As noted previously, Nursing Home Compare Quality Measure data and CASPER data are both calculated from MDS assessments.
44 CASPER – Certification And Survey Provider Enhanced Reports Quality measure reports are available to state surveyors and facility staff through CMS’ CASPER reporting systemPsychoactive measures were updated this spring to match Nursing Home Compare MeasuresPrior to the updates, only a Long Stay Psychoactive measure was present, and more conditions were excludedIf you compare your Long Stay measure from a CASPER report generated in February to one today, both your facility and benchmark rates will likely be higher todayQuality Measure reports are also available to state surveyors and facility staff through CMS’s CASPER reporting system. They contain QM information at the national, state, facility and resident level for a reporting period that you can choose as a CASPER user.In traditional survey, surveyors review these QM reports prior to visiting your facility to identify a preliminary sample of residents for focused and comprehensive review during survey. These residents are selected based on the QM percentiles that we will talk about on the next slide.Facility Quality Measure data are calculated weekly so they can be updated with information from the MDS assessments that have been submitted since the previous week’s data calculation.State and National benchmarks are calculated monthly on the first day of the month, but calculation is delayed by two months in order to allow for submission of late and corrected assessments.
45 Here is an example of an MDS 3 Here is an example of an MDS 3.0 Facility Quality Measure Report from CASPER reporting system.The third column is the numerator, how many residents triggered the measure.The fourth column is the Denominator- how many residents in your population were eligible to trigger this measure because they had a target assessment in the date range, were long stay residents, and were not excluded. In this example, the Denominator for Falls was 118, but it was only 113 for Long Stay Antipsychotic medications. That is because at least 5 residents were excluded due to missing data or because they had at least one of the psychotic or related conditions I described on the prior slides.The next column, facility observed percent, is numerator divided by the denominator– the residents who triggered the measure divided by the residents who were eligible to trigger. Antipsychotics is not one of the QMs with an adjusted percent, so that column will be the same as the observed percent.The last three columns are your benchmarks- the state average, the national average, and the national percentile. These benchmarks are moving targets. When I pulled one of these reports just a few months ago, the national norm was higher than it is today.The percentile column is reviewed by surveyors and tells you the percent of other facilities better than your facility.So, in this example, 32 out of 113 residents triggered this measure. 32 divided by 113 gives the facility a Psychoactive rate of 28.3%. The National average is lower, at 22.1%, and 77% of other facilities have a lower rate of Long Stay Antipsychotic use.
46 To see which residents trigger for your Psychoactive Medication quality measure, request the Resident Level Quality Measure Report and scan through the list of active and discharged residents that triggered for that QM during the selected time interval.Then, you can return to the listed MDS to see the coding for each of these residents make sure that no residents trigger who should have been excluded because they have a psychoactive condition that was missed when coding for the MDS.Also, look at the coding for N0410A. Residents who receive the medications for fewer days may be good candidates for interventions because they would not need dramatic reductions to no longer trigger the measure.
47 CASPER Reports vs. Nursing Home Compare TimeRun once a quarterUpdated frequentlyReport PeriodsUses most recent 3 months for LS and most recent 6 months for SSCustomized by userAverage Across QuartersAverage across several calendar quartersFor only one single report periodRisk Adjusted (related to timing)Calculations performed at different times based on national average
48 Translating QMs to QI Static Displays of Data Dynamic Displays of Data Benchmark: Compares your data for a particular interval of time against national or state norm or against your historical dataPercentile Ranking: (1-100) the percent of other facilities that are better than your facilityDynamic Displays of DataTrend Charts: Displays your performance over timeStatistical Process Control Charts: Your performance over time plus control limits that indicate how predictable your process is and expose significant eventsWhen focusing on improving your use of psychoactive medications, it is important to consider not just the source of the data, but how it will be displayed and analyzed.When you look at Nursing Home Compare or at a CASPER QM report, you are viewing a static display of data. During a single time interval, your rate is 7.5, the benchmark is This doesn’t tell you if you are getting better or worse. It also doesn’t tell you if that period of time is typical of your facility, or if 7.5 is abnormally high or low.Dynamic displays of Data, on the other hand, can reveal your performance over time and help you learn if your interventions are working. Trend charts simply display numbers or percentages week to week, month to month, quarter to quarter. SPC charts add control limits to help highlight abnormally high or low values.Use of these and other tools support quality assurance and performance improvement (QAPI) 5 Elements, especially Element 3: Feedback, Data Systems, and MonitoringIn this element, the facility implements systems that draw data from multiple sources to monitor care and services and compare performance indicators to benchmarks and targets.
49 Statistical Process Control Charts (SPC) Is variation due to “common cause” or “special cause”?Need periods of dataReview monthly for QI committee. Look for:5-7 points in a row increasing or decreasing5-7 points in a row climbing higher or lower than your meanA data point (or points) outside your control limitsBenchmark outside your control limitsOne of my favorite ways to view data is Statistical Process Control Charts.SPC charts help you decide if the changes in your data represent meaningful patterns, or if they are just ups and downs due to chance.To establish patterns, you have to start with enough time periods of data. We recommend months or quarters for QMs.When I look at an SPC chart, first I look for trends of 5-7 or more points. In this example, the facility’s rate of psychoactives is the red line. I can see the rate decreased every month from April to November, 2012 – 8 points in a row. If I had just compared November to December, I would have determined the facility was getting worse.The second thing I do is look at the average, calculated by adding my rate for all the months together and dividing by the number of the months. I look for 5-7 points in a row above or below the average. In this case, the last 6 months were below average, suggesting the average has changed.Finally, I look for points above the upper control limit or below the lower control limit. On this chart, those would be points outside of the gray area and would represent a month that was either significantly higher or lower than normal. Points outside of the limits should be investigated to see if there is a special cause. If one of my benchmarks, like the national norm, is below lower control limit, it tells me that I will never be below the national norm unless I make process changes.Looking at this chart, there are no cases of ‘special’ cause, but there is evidence of performance improvement. If a facility wide intervention had been put in place in March, this chart would suggest it worked. If the facility had merely looked at a benchmark report comparing the 2012 average to the national norm, the staff might have concluded that rates were slightly higher and missed the progress that has been made
50 Trend Charts in ExcelThe chart on the previous slide was created by the CareWatch program, but you can also create trend and SPC charts by yourself in excel.Just put the weeks/months/or quarters in columns and record your rate and any benchmark in the rows. So I looked at my CASPER report in January and put my rate, in cell B3, then I put my average in B4, and the National Norm in B5.I calculated the average by adding all of the months together and dividing by the number of months.If you wanted to add the upper and lower control limits, you could also build those equations into the spreadsheets, and I would be happy to discuss how those limits are calculated if you want to reach out after today’s session.After I had all of the columns filled in, I highlighted all of the cells and clicked the Insert tab. I clicked the line chart picture and the chart appeared in the spreadsheet.You can make a chart like this from the QM percentages, but you can also create a trend chart for anything else you can count. Just determine the time periods you will use and what you will be measuring.So if you want to see if a intervention is effective for a particular resident who is displaying combative behaviors such as hitting staff during dressing you could begin counting the number of times a week the resident hits staff before putting an intervention in place, such as playing soothing music during care. After the intervention, if the resident is less combative for 5 consecutive weeks, this suggests the intervention worked. If there is no change, or if the rate was lower the first week and then higher the second, we can conclude the music wasn’t enough to solve the issue.
51 Six Steps to Process Improvement Ensure data are complete and accurateIdentify opportunities for improvementLook for root cause of the current state (and determine if the process is stable)Set measurable goalsDevelop an action planFollow-up to evaluate the effectiveness of your action planIn this session, we have discussed the importance of ensuring that psychoactive medications are used appropriately and given you some suggestions for how to accomplish this in your facility. We have also detailed how CMS will be measuring facility antipsychotic rates and how you can trend your rates over time.When your facility embarks on any performance improvement project, including reducing rates of psychoactive medication use, there are six key steps to consider. These steps support QAPI and the Plan Do Study Act cycle.[Read Steps]By incorporating these steps with some of the ideas, techniques, and interventions we have discussed on today’s webinar, you may be able to reduce your use of psychoactive medications and improve the quality of life of your residents.Thank you so much for the opportunity to talk with you today, I will now turn the program over to Monika Werling to see if we have had any questions.
54 Contact Us!Ellen J. Mullins RN, Research and Development Director, The Compliance Store(334) ext. 2503Cheryl Swann RN-BC, BSN, WCC, LNHA, VP of Content, Relias Learningwww. reliaslearning.com(866) ext. 2004Theresa Schmidt MA, RAC-CT, Manager of Education, eHealth Data Solutions(740)
55 Full Quality Measure Calculations These will not be part of the presentation
56 NH Compare Calculation: Short-Stay Percent of Short-Stay Residents Who Newly Received Antipsychotic MedicationNumeratorShort-stay residents for whom one or more assessments in a lookback scan (not including the initial assessment) indicates that antipsychotic medication was received:For assessments with target dates on or before 03/31/2012: N0400A = .For assessments with target dates on or after 04/01/2012: N0410A = [1,2,3,4,5,6,7].DenominatorAll short-stay residents who do not have exclusions and who meet all of the following conditions:The resident has a target assessment, andThe resident has an initial assessment, andThe target assessment is not the same as the initial assessment.ExclusionsThe following is true for all assessments in the lookback scan (excluding the initial assessment):1.1 For assessments with target dates on or before 03/31/2012: N0400A = [-].1.2 For assessments with target dates on or after 04/01/2012: N0410A = [-].Any of the following related conditions are present on any assessment in a lookback scan:2.1 Schizophrenia (I6000 = ).2.2 Tourette’s Syndrome (I5350 = ).2.3 Huntington’s Disease (I5250 = ).The resident’s initial assessment indicates antipsychotic medication use or antipsychotic medication use is unknown:3.1 For initial assessments with target dates on or before 03/31/2012: N0400A = [1,-].3.2 For initial assessments with target dates on or after 04/01/2012: N0410A = [1,2,3,4,5,6,7,-].Note that residents are excluded from this measure if their initial assessment indicates antipsychotic medication use or if antipsychotic medication use is unknown on the initial assessment (see exclusion #3).
57 CASPER and NH Compare Calculation: Long-Stay Percent of Long-Stay Residents Who Received Antipsychotic MedicationNumeratorLong-stay residents with a selected target assessment where the following condition is true: antipsychotic medications received. This condition is defined as follows:For assessments with target dates on or before 03/31/2012: N0400A = .For assessments with target dates on or after 04/01/2012: N0410A = [1,2,3,4,5,6,7].DenominatorAll long-stay residents with a selected target assessment, except those with exclusions.ExclusionsThe resident did not qualify for the numerator and any of the following is true:1.1. For assessments with target dates on or before 03/31/2012: N0400A = [-].1.2. For assessments with target dates on or after 04/01/2012: N0410A = [-].Any of the following related conditions are present on the target assessment (unless otherwise indicated):2.1 Schizophrenia (I6000 = ).2.2 Tourette’s Syndrome (I5350 = ).2.3 Tourette’s Syndrome (I5350 = ) on the prior assessment if this item is not active on the target assessment and if a prior assessment is available.2.4 Huntington’s Disease (I5250 = ).